Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4,827
Frequently Asked Questions
What is Market Cap of Evotec SE - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Evotec SE - ADR market cap is $1.24B.
What is the 52-week high for Evotec SE - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Evotec SE - ADR 52 week high is $5.64 as of September 07, 2025.
What is the 52-week low for Evotec SE - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Evotec SE - ADR 52 week low is $2.84 as of September 07, 2025.
What is Evotec SE - ADR stock price today?
Evotec SE - ADR stock price today is $3.48.
What was Evotec SE - ADR stock price yesterday?
Evotec SE - ADR stock price yesterday was $3.37.
What is the PE ratio of Evotec SE - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Evotec SE - ADR’s P/E ratio is -7.28.
What is the Price-to-Book ratio of Evotec SE - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Evotec SE - ADR P/B ratio is 1.2450.
What is the 50-day moving average of Evotec SE - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Evotec SE - ADR 50-day moving average is $3.90.